Zimbabwe has rejected a substantial American healthcare agreement valued at $367m (£272m) over five years because of Washington's request for confidential biological samples.
This rejection was revealed after a internal memorandum dated December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".
An official spokesperson has since clarified that the US was requesting health data for scientific study and commercial gain while was unwilling to guarantee the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate task of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for further dialogue to reach a agreement suitable to all parties so the nation's vital HIV programme can continue.
Broader Background
Zimbabwe's decision follows a comparable situation in Kenya, where a high court suspended a related deal with the US following legal challenges were filed about the security of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump claimed its spending was "wasteful" and his administration was pursuing government-to-government deals to enhance transparency and accountability.
According to reports, 16 nations in Africa have to date signed similar agreements, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation might have yielded immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment via American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its biological resources and data indefinitely, with no corresponding promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"In essence, our nation would supply the basic resources for medical research without any assurance that the final treatments would be available to our people if a new pandemic arise."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were upending systems previously set up via the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to manage future pandemics.
"This mechanism is designed to ensure that when a country provides its information, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."
These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to further dialogue with our US partners on how subsequent collaboration might be designed in a manner that honours the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but suggested that talks need to persist since a large portion of the country's HIV programmes relied on external financing.
"In cases where technical issues arise, such as those involving data governance or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," it added.
This impasse underscores the ongoing debate between accepting crucial foreign assistance and protecting a country's data in an ever more interconnected world.